Sorafenib/Docetaxel Dose Escalation Trial
NCT00562523
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
Sorafenib (Nexavar, BAY43-9006)
Sponsor
Bayer
Collaborators
[object Object]